相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
Fang Sun et al.
ADVANCED SCIENCE (2021)
Immunotherapeutic approach for advanced pancreatic adenocarcinoma
Jasmeet Kaur et al.
IMMUNOTHERAPY (2021)
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Cheng Qin et al.
MOLECULAR CANCER (2020)
Pancreatic Cancer and Its Microenvironment-Recent Advances and Current Controversies
Kinga B. Stopa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
Yizhi Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Is Screening for Pancreatic Cancer in High-Risk Individuals One Step Closer or a Fool's Errand?
Phil A. Hart et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Targeting carbon nanotubes based on IGF-1R for photothermal therapy of orthotopic pancreatic cancer guided by optical imaging
Guan-Hua Lu et al.
BIOMATERIALS (2019)
Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis
Madelaine G. van Mackelenbergh et al.
CANCERS (2019)
MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment
Qi Zou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
Assaf Zinger et al.
ACS NANO (2019)
Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Nora B. Henrikson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle
Xingli Cun et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art
Sally A. El-Zahaby et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles
Cristiana Maria Grapa et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
Divya Thomas et al.
MOLECULAR CANCER (2019)
Nanostructured carriers as innovative tools for cancer diagnosis and therapy
Chiara Martinelli et al.
APL BIOENGINEERING (2019)
Enhanced selective cellular uptake and cytotoxicity of epidermal growth factor-conjugated liposomes containing curcumin on EGFR-overexpressed pancreatic cancer cells
Uyen Minh Le et al.
JOURNAL OF DRUG TARGETING (2018)
Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
Huan Meng et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Imaging Cancer Metabolism
Milica Momcilovic et al.
BIOMOLECULES & THERAPEUTICS (2018)
MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior
Shuo Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer
Ayse Ceren Mutgan et al.
MOLECULAR CANCER (2018)
Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells
Kei Takahashi et al.
ONCOGENE (2018)
Pancreatic Cancer Metabolism: Molecular Mechanisms and Clinical Applications
Abdel Nasser Hosein et al.
CURRENT ONCOLOGY REPORTS (2018)
Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging
Xiao Chen et al.
EBIOMEDICINE (2018)
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
Xuexiang Han et al.
NATURE COMMUNICATIONS (2018)
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Eameema Muntimadugu et al.
PHARMACOLOGICAL RESEARCH (2017)
Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies
Ana Rebelo et al.
CURRENT DRUG METABOLISM (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Cristoforo Grasso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy
Lei Zhu et al.
CANCER LETTERS (2017)
Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
Iole Maria Di Gangi et al.
Oncotarget (2016)
Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer
Xiangsheng Liu et al.
ACS NANO (2016)
Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation
Seung Min Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Pancreatic cancer screening using a multiplatform human serum metabolomics system
Arata Sakai et al.
BIOMARKERS IN MEDICINE (2016)
Results of the phase Ib portion of a phase I/II trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of metastatic pancreatic cancer.
Nathan Bahary et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma
Chao Lin et al.
MEDICINE (2016)
Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer
Lingxi Xing et al.
THERANOSTICS (2016)
Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials
Minnie Au et al.
BIOMEDICINES (2016)
IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer
Hongyu Zhou et al.
ACS NANO (2015)
Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Lei Miao et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Targeting Epidermal Growth Factor Receptor-Related Signaling Pathways in Pancreatic Cancer
Philip A. Philip et al.
PANCREAS (2015)
Early Detection of Sporadic Pancreatic Cancer Strategic Map for Innovation-A White Paper
Barbara J. Kenner et al.
PANCREAS (2015)
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab
Josep Tabernero et al.
TARGETED ONCOLOGY (2015)
Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
Maria Ignez Braghiroli et al.
ECANCERMEDICALSCIENCE (2015)
Dual Blockade of Epidermal Growth Factor Receptor and Insulin-Like Growth Factor Receptor-1 Signaling in Metastatic Pancreatic Cancer Phase Ib and Randomized Phase II Trial of Gemcitabine, Erlotinib, and Cixutumumab Versus Gemcitabine Plus Erlotinib (SWOG S0727)
Philip A. Philip et al.
CANCER (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Surface engineered antifouling optomagnetic SPIONs for bimodal targeted imaging of pancreatic cancer cells
Xiaohui Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis
Song Nie et al.
JOURNAL OF PROTEOME RESEARCH (2014)
MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer
Prajakta S. Kulkarni et al.
MOLECULAR PHARMACEUTICS (2014)
Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study
Agata I. Rembielak et al.
TRANSLATIONAL ONCOLOGY (2014)
Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer
Joshua McCarroll et al.
Frontiers in Physiology (2014)
IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer
Toshiki Hirakawa et al.
BMC CANCER (2013)
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
S. Tonack et al.
BRITISH JOURNAL OF CANCER (2013)
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy
E. R. Camp et al.
CANCER GENE THERAPY (2013)
Challenges and opportunities for oncology biomarker discovery
Avisek Deyati et al.
DRUG DISCOVERY TODAY (2013)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Marcia Irene Canto et al.
GUT (2013)
Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment
Murali M. Yallapu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma
Alexander Benedikt Leichtle et al.
METABOLOMICS (2013)
Plectin-1 targeted AAV vector for the molecular imaging of pancreatic cancer
Prasad R. Konkalmatt et al.
FRONTIERS IN ONCOLOGY (2013)
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
H. L. Kindler et al.
ANNALS OF ONCOLOGY (2012)
Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades
Jordan M. Winter et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer
Li Deng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Raman spectroscopy as a detection and analysis tool for in vitro specific targeting of pancreatic cancer cells by EGF-conjugated, single-walled carbon nanotubes
Alokita Karmakar et al.
JOURNAL OF APPLIED TOXICOLOGY (2012)
Mesothelin-Targeted Agents in Clinical Trials and in Preclinical Development
Ronan J. Kelly et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
Jordan M. Winter et al.
PLoS One (2012)
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
Simon Rieder et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2
Surabhi Dangi-Garimella et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Plectin-1 as a Novel Biomarker for Pancreatic Cancer
Dirk Bausch et al.
CLINICAL CANCER RESEARCH (2011)
Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
S. Buenger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Autoantibody signatures: progress and perspectives for early cancer detection
C. Desmetz et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer
Chitta Ranjan Patra et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
Naru Kondo et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
Sant P. Chawla et al.
MOLECULAR THERAPY (2010)
Targeted Delivery Systems for Oligonucleotide Therapeutics
Bo Yu et al.
AAPS JOURNAL (2009)
Clinical Applications of Metabolomics in Oncology: A Review
Jennifer L. Spratlin et al.
CLINICAL CANCER RESEARCH (2009)
Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
Joshua G. Barton et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Magnetic nanoparticles in MR imaging and drug delivery
Conroy Sun et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Gemcitabine resistance in pancreatic cancer: Picking the key players
Michael P. Kim et al.
CLINICAL CANCER RESEARCH (2008)
The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Mert Erkan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (rexin-G) in patients with advanced pancreatic cancer
Evanthia Galanis et al.
MOLECULAR THERAPY (2008)
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
T. Hamaguchi et al.
BRITISH JOURNAL OF CANCER (2007)
Surgery for recurrent pancreatic ductal adenocarcinoma
Joerg Kleeff et al.
ANNALS OF SURGERY (2007)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
In vivo imaging of tumor response to therapy using a dual-modality imaging strategy
Z Medarova et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis
DV Gold et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas
E Ryschich et al.
EUROPEAN JOURNAL OF CANCER (2004)
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas
HF Frierson et al.
HUMAN PATHOLOGY (2003)
Application of mesothelin immunostaining in tumor diagnosis
NG Ordonez
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials
M Bloomston et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis
P Mews et al.
GUT (2002)
分享论文
